Abstract
Objective:
The plasminogen system has been proposed to participate in vascular remodeling and angiogenesis. Although plasmin-mediated proteolysis could contribute these processes, proteolytic targets for plasmin and their downstream effector molecules are yet to be fully defined. The aim of the present study was to elucidate potential mechanisms by which plasmin affects various cellular processes.
Methods and results:
Plasmin upregulated the expression of Cyr61, a growth factor-like gene that has been implicated in cell proliferation, adhesion, and migration. Plasmin-induced gene expression is dependent on its proteolytic activity and requires its binding to cells. Studies that used wild-type fibroblasts and fibroblasts derived from PAR-1- and PAR-2-deficient mice showed that plasmin induced Cyr61 gene expression in wild-type fibroblasts and PAR-2-deficient cells but not in PAR-1-deficient cells. Consistent with this, plasmin induced the activation of p44/42 mitogen-activated protein kinase in wild-type, PAR-2 -/- cells but not in PAR-1 -/- cells. In contrast with thrombin, plasmin failed to induce Ca2+ signaling in fibroblasts.
Conclusions:
Plasmin induced an angiogenic and wound-healing promoter, Cyr61, in fibroblasts through activation of PAR-1. Plasmin-induced Cyr61 expression is mediated via the p44/42 mitogen-activated protein kinase pathway independent of Ca2+ signaling.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Butadienes / pharmacology
-
Caenorhabditis elegans Proteins*
-
Calcium / metabolism*
-
Calcium Signaling / drug effects
-
Calcium Signaling / physiology
-
Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
-
Cell Line
-
Cysteine-Rich Protein 61
-
Cytoplasm / chemistry
-
Cytoplasm / enzymology
-
Enzyme Activation / physiology
-
Enzyme Inhibitors / pharmacology
-
Fibrinolysin / physiology*
-
Fibroblasts / chemistry*
-
Fibroblasts / drug effects
-
Fibroblasts / enzymology
-
Fibroblasts / metabolism*
-
Flavonoids / pharmacology
-
Gene Expression Regulation / drug effects
-
Gene Expression Regulation / genetics*
-
Gene Expression Regulation / physiology
-
Growth Substances / genetics*
-
Growth Substances / physiology
-
Humans
-
Immediate-Early Proteins / genetics*
-
Immediate-Early Proteins / physiology
-
Intercellular Signaling Peptides and Proteins*
-
MAP Kinase Signaling System / drug effects
-
MAP Kinase Signaling System / genetics*
-
Mice
-
Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase 1 / genetics*
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinases / genetics*
-
Nitriles / pharmacology
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / deficiency
-
Protein Serine-Threonine Kinases / metabolism
-
Receptor, PAR-1
-
Receptor, PAR-2
-
Receptors, Thrombin / antagonists & inhibitors
-
Receptors, Thrombin / deficiency
-
Receptors, Thrombin / genetics
-
Receptors, Thrombin / physiology*
-
Thrombin / physiology
-
Up-Regulation / drug effects
-
Up-Regulation / physiology
-
Wound Healing / genetics
-
Wound Healing / physiology
Substances
-
Butadienes
-
CCN1 protein, human
-
CCN1 protein, mouse
-
Caenorhabditis elegans Proteins
-
Cysteine-Rich Protein 61
-
Enzyme Inhibitors
-
Flavonoids
-
Growth Substances
-
Immediate-Early Proteins
-
Intercellular Signaling Peptides and Proteins
-
Nitriles
-
Receptor, PAR-1
-
Receptor, PAR-2
-
Receptors, Thrombin
-
U 0126
-
Protein Serine-Threonine Kinases
-
Calcium-Calmodulin-Dependent Protein Kinases
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
Mitogen-Activated Protein Kinases
-
Thrombin
-
Fibrinolysin
-
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
-
Calcium